Protective effect of ascorbic acid in experimental gastric cancer: Reduction of oxidative stress

World Journal of Gastroenterology

Volumn 9, Issue 3, 2003, Pages 446-448

  Oliveira, Claudia P M S ^a   Kassab, Paulo ^a   Lopasso, Fabio P ^a   Souza, Heraldo P ^a   Janiszewski, Mariano ^a   Laurindo, Francisco R M ^a   Iriya, Kioshi ^a   Laudanna, Antonio A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; EOSIN; HEMATOXYLIN; NITROBLUE TETRAZOLIUM; REACTIVE OXYGEN METABOLITE;

ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUODENOGASTRIC REFLUX; GASTROJEJUNOSTOMY; HISTOPATHOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTECTION; RAT; SAMPLING; STAINING; STOMACH ADENOCARCINOMA; STOMACH MUCOSA; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 0037347931     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i3.446     Document Type: Article

References (14)

1. Correa P. A new paradigm for human gastric carcinogenesis. J Clin Gastroenterol 2000; 30: 381-385
2. Reed PI, Vitamin C. Helicobacter pylori infection and gastric carcinogenesis. Int J Vitam Nutr Res 1999; 69: 220-227
3. Zhang ZW, Patchett SE, Perrett D, Katelaris PH, Domizio P, Farthing MJG. The relation between gastric vitamin C concentrations, mucosa histology, and Cag A seropositivity in the human stomach. Gut 1998; 43: 322-326
4. Farinati F, Cardin R, Degan P, Rugge M, Di Mario F. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut 1998; 42: 351-356
5. Correa P, Malcom G, Schmidt B, Fontham E, Ruiz B, Bravo JC, Bravo LE, Zarama G, Realpe JL. Antioxidants micronutrients and gastric cancer. Aliment Pharmacol Ther 1998; 12 (Suppl1): 73-82
6. Tsubono Y, Tsugane S, Gey KF. Plasma antioxidant vitamins and carotenoid in five Japanese populations with varied mortality from gastric cancer. Nutr Cancer 1999; 34: 56-61
7. Mowat C, Carswell A, Wirz A, McColl KE. Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology 1999; 116: 813-822
8. Dabrowska-Ufniarz E, Dzieniszewski J, Jaroz M, Wartanowicz M. Vitamin C concentration in gastric juice in patients with precancerous lesions of the stomach and gastric cancer. Med Sci Monit 2002; 8: CR96-103
9. You WC, Zhang L, Gail MH, Chang YS, Liu WD, Ma JL, Li JY, Jin ML, Hu YR, Yang CS, Blaser MJ, Correa P, Blot WJ, Fraumeni JF Jr, Xu GW. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000; 92: 1607-1612
10. Yamaguchi N, Kakizoe T. Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Lancet Oncol 2001; 2: 88-94
11. Zhang ZW, Abdullahi M, Farthing MJ. Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori. Gut 2002; 50: 165-169
12. Jacobs EJ, Connell CJ, McCullough ML, Chao A, Jonas CR, Rodriguez C, Calle EE, Thun MJ. Vitamin C, vitamin E, and multivitamin supplement use and stomach cancer mortality in the Cancer Prevention Study II cohort. Cancer Epidemiol Biomarkers Prev 2002; 11: 35-41
13. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000; 92: 1881-1888
14. Dixon MF. Prospects for intervention in gastric carcinogenesis: Reversibility of gastric atrophy and intestinal metaplasia. Gut 2001; 49: 2-4